Mikael Elofsson Selected Research

INP 0341

12/2020	Attenuation of Pseudomonas aeruginosa infection by INP0341, a salicylidene acylhydrazide, in a murine model of keratitis.
8/2010	Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikael Elofsson Research Topics

Disease

21	Infections 01/2022 - 02/2005
7	Neoplasms (Cancer) 04/2022 - 04/2004
3	Bacterial Infections (Bacterial Infection) 01/2020 - 11/2007
2	Tuberculosis (Tuberculoses) 10/2019 - 01/2019
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2012 - 08/2010
2	Keratoconjunctivitis 06/2009 - 02/2007
1	Keratitis 12/2020
1	Pseudomonas Infections 12/2020
1	Eye Infections 10/2020
1	Flavivirus Infections 01/2020
1	Virus Diseases (Viral Diseases) 01/2018
1	Fever (Fevers) 01/2018
1	Starvation 08/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2014
1	Chronic Disease (Chronic Diseases) 01/2014
1	Ischemia 08/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2010
1	Adenoviridae Infections (Adenovirus Infections) 09/2010

Drug/Important Bio-Agent (IBA)

5	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2022 - 02/2007
4	Type III Secretion SystemsIBA 01/2022 - 08/2014
4	Antiviral Agents (Antivirals)IBA 01/2020 - 02/2007
3	Pharmaceutical PreparationsIBA 10/2019 - 07/2014
3	Anti-Infective Agents (Microbicides)IBA 01/2014 - 08/2010
2	HCEIBA 01/2022 - 01/2019
2	INP 0341IBA 12/2020 - 08/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2019
1	Silicon Dioxide (Silica)FDA LinkGeneric 04/2022
1	Molecularly Imprinted PolymersIBA 04/2022
1	Polystyrenes (Polystyrene)IBA 04/2022
1	LectinsIBA 04/2022
1	Glucose (Dextrose)FDA LinkGeneric 08/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	exoenzyme SIBA 01/2018
1	Red Fluorescent ProteinIBA 01/2018
1	AerosolsIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	LignansIBA 10/2015
1	TriazolesIBA 09/2015
1	Poly (ADP-Ribose) Polymerase-1IBA 05/2015
1	HydrazonesIBA 09/2014
1	IonsIBA 09/2014
1	IronIBA 08/2014
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2013
1	TransferasesIBA 08/2013
1	Adenosine Diphosphate (ADP)IBA 08/2013
1	hopeaphenolIBA 01/2013
1	Acyclovir (Aciclovir)FDA LinkGeneric 11/2012
1	Local Anti-Infective Agents (Antiseptics)IBA 10/2012
1	ChromatinIBA 09/2012
1	Sialic AcidsIBA 06/2009
1	benzamideIBA 11/2007
1	ThiadiazolesIBA 11/2007
1	INP 0400IBA 09/2006
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 02/2006
1	LactonesIBA 02/2006
1	Cancer VaccinesIBA 02/2006
1	MucinsIBA 02/2006
1	3'-sialyllactoseIBA 02/2005
1	LigandsIBA 04/2004
1	GlycolipidsIBA 04/2004

Therapy/Procedure

1	Therapeutics 11/2012
1	Hematopoietic Stem Cell Transplantation 09/2010